And the chemical modeling researchers were playing with machine learning/neural nets in the previous century (Gasteiger, amongst others). The problem then, as now, was that the number of statistical methods to build models greatly exceeded the amount of data that was available. And even companies that have grown by acquisition (Pfizer, for example) didn't get clean data they could aggregate - and much of it was on paper.
Edit: I'm not the only one imagining such a thing: https://www.sciencedirect.com/science/article/pii/S095816692...
The SAMPLE system used four different autonomous agents, each of which designed slightly different proteins. These agents search the fitness landscape for a protein and then proceed to test and refine it over 20 cycles. The entire process took just under six months. It took one hour to assemble genes for each protein, one hour to run PCR, three hours to express the proteins in a cell-free system, and three hours to measure each protein’s heat tolerance. That’s nine hours per data point! The agents had access to a microplate reader and Tecan automation system, and some work was also done at the Strateos Cloud Lab.
SAMPLE made sugar-cutting enzymes that could tolerate temperatures 10°C higher than even the best natural sequence, called Bgl3. The AI agents weren’t “told” to enhance catalytic efficiency, but their designs also had catalytic efficiencies that matched or exceeded Bgl3.
[1] https://www.biorxiv.org/content/10.1101/2023.05.20.541582v1 [2] https://www.readcodon.com/i/122504181/ai-agents-design-prote...
I'm taking bioinformatics next semester, which I hope will give me the lay of the land from a code perspective, but I really don't know what I'm getting into here.
Any advice?
The difference is, their ML is often operating in regulated environments. Because unlike advertising people can die from mistakes. Also the data isn't cheap, can't go on Google and just download a terabyte of it. Not because scientists are sneaky. But because some experiments require five million in equipment and months to aquire. Then, the findings there don't often map to almost anything else in any way shape or form.
Statistical models in some fields have to be approved by a government agency or follow standard practices. This can take years and cost a lot of money.
ML could assist with the definition of conditions and eventually the interpretation of the analytical data, but not at all with all the physical processing which is where the difficulty really is.
In the last 5 years, the industry has moved to using the LabCyte Echo in high-well-count plates for this kinda work.
Industry is broadly interested in this kinda thing, with efforts like [1] [2] (me)